baber/WOPTO huggingface dataset:
Patent NZ-568337-A (NZ)
Title: Tiered hinge-lid pack of smoking articles
Inventor: WEISS JACQUES
IPC: B65D85/10
Filed: 2006-12-05
Abstract: A hinge-lid pack of smoking articles such as cigarettes comprises a box portion (2), a lid portion (4) hinged to the box portion, and at least two longitudinally offset tiers (18) (20) (22) of smoking articles mounted in the box portion. Each of the at least two tiers (18) (20) (22) comprises a separately wrapped bundle of smoking articles. In one embodiment the smoking articles in each of the tiers are of substantially the same length and the upper ends and the lower ends of the separately wrapped bundles of smoking articles are longitudinally offset relative to one another. In another embodiment the smoking articles in each of the tiers are of different length and the upper ends of the separately wrapped bundles of smoking articles are longitudinally offset relative to one another.
Patent NZ-569083-A (NZ)
Title: Oil-in-water formulation of avermectins
Inventor: PEDERSEN MORTEN
IPC: A01N25/04
Filed: 2006-11-17
Abstract: Disclosed is a concentrated oil-in-water emulsion formulation for crop protection against pests, comprising· (a) one or more pesticidal active ingredients selected among avermectins; (b) one or more solvents selected among (C1-C20)-alkyl (C5-C22)-fatty acid esters; (c) an emulsifier system comprising one or more surfactants; (d) water; and (e) one or more co-solvents having a solubility in water of less than 10% at 25 Deg C; wherein the pH-value of the emulsion is higher than 3 and the amount by weight of co-solvent is equal to or higher than the amount by weight of avermectin.
Patent NZ-571699-A (NZ)
Title: Liquid composition comprising an aspartic protease
Inventor: HAAN DE ANDRE
IPC: C12N9/58
Filed: 2007-04-12
Abstract: Disclosed is a liquid composition comprising: - an aspartic protease; - an inorganic salt; and - a polyalcohol; in the sum concentration of sorbate, benzoate and alkyl esters of para-hydroxybenzoate in the liquid composition is less than 0.010 mol/l; the standard plate counts are less than or equal to 100 in 1 ml; the yeast count is less than or equal to 10 in 1 ml; and the mould count is less than or equal to 10 in 1 ml, which composition comprises at least 80 g/l and less than 160 g/l of an inorganic salt or of a combination of inorganic salts; and at least 40 g/l of a polyalcohol or of a combination of polyalcohols.
Patent NZ-571922-A (NZ)
Title: Tool for gutting fish with suction tube device to clamp/squeeze entrails, and end and radial openings
Inventor: PAUL SOHN CARSTEN
IPC: A22C25/14
Filed: 2007-04-11
Abstract: The disclosure relates to a tool for gutting fish (not shown) which have been opened at the stomach cavity, with the tool (13) designed as a suction element (23) for suctioning the guts, said tool being characterized in that an element (35) for the gripping and/or compressing of the guts to be removed is attached to the suctioning element (23). The disclosure also relates to a device for gutting fish which have been opened at the stomach cavity, encompassing a tool for suctioning the guts, a measuring instrument (not shown) which is configured in such a way as to record specific fish data, and at least one control unit to operate the tool (13) in accordance with the specific fish data captured by the measuring instrument. The device is characterized in that the tool (13) is configured as described above. The disclosure also relates to a corresponding method for gutting fish.
Patent NZ-576592-A (NZ)
Title: Crystalline modification v of fipronil, process for its preparation and use to prevent parasites on animals
Inventor: SAXELL HEIDI EMILIA
IPC: A01N25/00
Filed: 2007-11-05
Abstract: Disclosed is solid fipronil (formula I) comprising at least 98% by weight of the crystalline modification V fipronil showing, in an X-ray powder diffractogram recorded using Cu-Ka radiation at 25 degrees C, at least 3 of the following reflexes: (1) 2theta = 10.3 ± 0.2 degrees (2) 2theta = 11.1 ± 0.2 degrees (3) 2theta = 13.0 ± 0.2 degrees (4) 2theta = 16.2 ± 0.2 degrees (5) 2theta = 20.3 ± 0.2 degrees (6) 2theta = 31.5 ± 0.2 degrees and a melting point in the range of 201 to 203 degrees C. Also disclosed is a process for preparing crystalline modification V fipronil comprising the steps of: step i) preparing a solution of a solid form of fipronil being different from the crystalline modification V in a solvent S selected from dimethylsulfoxide having a temperature of 100 degrees C to 150 degrees C or acetonitrile having a temperature of 60 degrees C to 81degrees C; step ii) effecting crystallization of fipronil from the solution; and step iii) isolating the resulting precipitate. Also disclosed is the use of the crystalline modification V fipronil for the control of pests and methods of control of pests such as parasites, insects, arachnids or plant nematodes.
Patent NZ-581962-A (NZ)
Title: Connection between fan housing and separable outlet connection tube
Inventor: MARSH BEN
IPC: E21F1/06
Filed: 2008-06-20
Abstract: An improved fan assembly is disclosed. The assembly includes: a housing (20) having a downwardly opening mouth for drawing in air and a laterally opening exhaust air outlet (30); a separable outlet connection tube (50) having a downwards facing upper surface (55); a pivot joint defining a hinge axis between the top edge and the outlet tube; a protrusion and recess pair; and a clip (54) and co-operating surface (42) pair. One of the protrusion and the recess is located on the tube and the other on a first side edge of the housing, and one of the clip and co-operating surface is located on the tube and the other on a second side edge of the housing. The downwards facing upper surface of the outlet connection tube is positionable onto the top edge adjacent the outlet so as to form the pivot joint. The tube is pivoted downwards, the protrusion and recess pair engage each other and the clip engages with the co-operating surface to retain the tube to the outlet.
Patent NZ-595706-A (NZ)
Title: L-ornithine phenyl acetate and methods of making thereof
Inventor: BEHLING JIM
IPC: C07C57/32
Filed: 2010-04-01
Abstract: 595706 Provided are crystalline forms of L-ornithine phenyl acetate, as depicted in structure (V), and methods of making the same. The crystalline form may, in some embodiments, be of Form I, II, III or V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
Patent NZ-599777-A (NZ)
Title: Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
Inventor: KELER TIBOR
IPC: A61K39/395
Filed: 2008-11-07
Abstract: 599777 Disclosed is a molecular conjugate comprising an antigen linked to a human monoclonal antibody which binds to human Dendritic and Epithelial Cell 205 receptor (DEC-205), wherein the antibody comprising the combination of CDR sequences as defined below. IYGMH , VIWYDGSNKYYADSVKG, APHFDY, RASQGISSWLA, AASSLQS & QQYNSYPYT; IYGMH, VIWYDGSNKYYADSVKG, APHFDY, RASQGISSALA, DASSLES & QQFNSYPLT; TYGMH, IIWYDGGNKYYADSVKG, DFYWYFDL, RASQSVSSYLA, DASNRAT & QQRRT; SYNMH, FIWYDGSNKYYGDSVKG, EELGIGWYFDL, RASQSVSSYLA, DASNRAT & QQRRT; or SYNMH, VIWYDGSNKYYGDSVKG, EELGIGWYFDL, RASQGISSALA, DASSLES & QQFNSYPH.
Patent NZ-600737-A (NZ)
Title: Method for influencing sex selection in artificial insemination and apparatus for same
Inventor: PFISTERSHAMMER JOSEF
IPC: A61D19/02
Filed: 2010-11-24
Abstract: Disclosed is a method for influencing sex selection in artificial insemination, the method characterised by the exposure of unsexed semen to antibodies to sex specific antigens present on spermatozoa carrying chromosomes of an undesired sex during the physical act of artificial insemination, whereby the spermatozoa to which the sex specific antibodies are bound are generally unable to effect fertilisation of an egg, such that fertilisation is likely to be effected by spermatozoa carrying chromosomes of a desired sex.
Patent NZ-608387-A (NZ)
Title: Prodrugs comprising an exendin linker conjugate
Inventor: CLEEMANN FELIX
IPC: C07K17/08
Filed: 2011-09-16
Abstract: Provided are prodrugs, comprising an exendin linker conjugate D-L, wherein -D represents an exendin moiety and -L is a non-biologically active linker moiety. The -L moiety is derived from D-alanine and comprises -L1, depicted in formula (I), which can be substituted by L2-Z, wherein L2 is a single chemical bond or a spacer and Z is a hydrogel.
Patent NZ-609609-A (NZ)
Title: Method and apparatus of delta quantization parameter processing for high efficiency video coding
Inventor: HUANG YU-WEN
IPC: H04N7/24
Filed: 2011-10-21
Abstract: 609609 A method for coding and decoding of video pictures is capable of facilitating flexible delta quantisation parameter (QP). The method comprises receiving a leaf coding unit (CU), determining a quantization parameter (QP) minimum CU size to transmit QP for the leaf CU and inserting the QP if the leaf CU size is larger than or equal to the QP minimum CU size.
Patent NZ-610972-A (NZ)
Title: Modulators of atp-binding cassette transporters
Inventor: ZHOU JINGLAN
IPC: C07D209/08
Filed: 2009-11-06
Abstract: Disclosed herein is the use of a compound of formula (II) and a pharmaceutically acceptable salt thereof in the manufacture of a medicament for treating male infertility or pancreatic insufficiency, wherein the variables are defined in the specification. These compounds are modulators of ATP-Binding Cassette (”ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (”CFTR”), and are useful for treating ABC transporter mediated condition, disease, or disorder.
Patent NZ-615369-A (NZ)
Title: A lottery
Inventor: PIPER JAMES WILLIAM
IPC: G07C15/00
Filed: 2012-08-15
Abstract: Disclosed is a computerised gaming system with at least one computer system. The computer system records entries to a game and determines one or more winners of the game. The game has an entry fee and is conducted in at least a first phase and a final phase. The first phase consists of one or more games from which the number of entries in each first phase game is reduced substantially so that the number of entries which progress from the first phase games to the final phase is substantially less than the number of entries in the first phase games. The entries in the final phase are entered into a final game which game includes a final prize which may or may not be won. The entry fee for all first phase entries includes an amount which is allocated to be set aside and/or used to fund or to purchase insurance against the winning of the final prize.
Patent NZ-622900-A (NZ)
Title: Multivalent meningococcal polysaccharide-protein conjugate vaccine
Inventor: RYALL ROBERT P
IPC: A61K47/48
Filed: 2002-01-22
Abstract: Disclosed is an immunological composition comprising a mixture of four distinct and separately made protein-capsular polysaccharide conjugates, wherein the first conjugate comprises purified Neisseria meningitidis capsular polysaccharide of serogroup W-135 conjugated to a carrier protein, the second conjugate comprises purified N. meningitides capsular polysaccharide of serogroup Y conjugated to a carrier protein, the third conjugate comprises purified N. meningitidis capsular polysaccharide of serogroup A conjugated to a purified carrier protein, and the fourth conjugate comprises purified N. meningitidis capsular polysaccharide of serogroup C conjugated to a carrier protein, wherein the immunological composition elicits, in children less than two years of age, a primary serum IgG response and a serum bactericidal antibody response to each of the N. meningitidis serogroups A, C, W-135 and Y capsular polysaccharides, wherein said serum bactericidal antibody response is higher than that elicited by the licensed, unconjugated, tetravalent A, C, W-135 and Y meningococcal capsular polysaccharide vaccine, and further wherein the immunological composition is capable of eliciting a booster anamnestic IgG response to each of the N. meningitidis serogroups A, C, W-135 and Y capsular polysaccharides.
Patent NZ-701241-A (NZ)
Title: Novel composition for preparing polysaccharide fibers
Inventor: O’BRIEN JOHN P
IPC: D01F9/00
Filed: 2013-05-23
Abstract: Solutions formed by combining poly(α(1→3) glucan) with CS2 in aqueous alkali metal hydroxide solution have been shown to produce the xanthated form of the poly(α(1→3) glucan). The solutions so formed have been shown to be useful for solution spinning into fiber of poly(α(1→3) glucan) when the spun fiber is coagulated in an acidic coagulation bath. The fibers so produced exhibit desirable physical properties. The poly(α(1→3) glucan) employed was synthesized by fermentation.
Patent NZ-702647-A (NZ)
Title: Heteroaromatic methyl cyclic amine derivative
Inventor: NOZAWA DAI
IPC: C07D413/14
Filed: 2013-06-13
Abstract: A heteroaromatic methyl cyclic amine derivative represented by formula (IA) or a pharmaceutically acceptable salt thereof is useful for treatment or prophylaxis of diseases such as sleep disorder, depression, anxiety disorder, panic disorder, schizophrenia, drug dependence, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, eating disorder, cephalalgia, hemicrania, pain, digestive diseases, epilepsy, inflammation, immune-related diseases, endocrine-related diseases and hypertension, on the basis of an orexin (OX) receptor antagonist activity.
Patent NZ-712458-A (NZ)
Title: Nitrification inhibitors and formulations
Inventor: ARPAD PHILLIP
IPC: C05G3/90
Filed: 2015-09-17
Abstract: The present disclosure generally relates to nitrification inhibitors and formulations comprising nitrification inhibitors. The present disclosure also relates to the use of the nitrification inhibitors and formulations for application to fertilisers, plants, agricultural areas (e.g. soils or pastures), animal by-products containing urea such as manure or urine, or with other agricultural products, for reducing or inhibiting the oxidation of ammonium nitrogen to nitrite nitrogen, such as the oxidation of ammonia based fertilisers.
Patent NZ-715195-A (NZ)
Title: Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
Inventor: SHECHTER SHARON
IPC: C07D405/12
Filed: 2014-07-03
Abstract: The invention generally relates to substituted benzofuranyl and substituted benzoxazolyl compounds, and more particularly to compounds represented by Structural Formula (VII) or (VIII) : or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula (VII) or (VIII), or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.
Patent NZ-716282-A (NZ)
Title: Passenger and vehicle elevator system
Inventor: DEZER GIL
IPC: B66B9/00
Filed: 2013-07-23
Abstract: The increasing cost of urban land, together with the need to provide affordable high density housing, as well as low-cost commercial or professional office space, presents several problems in the development of building complexes, particularly including vehicle parking facilities. One solution is the development of multi-story garages for motor vehicles directly adjacent to, or within, the buildings that include the dwelling units to be occupied by the persons normally parking their vehicles in the garage. However, multi-story garages can be inconvenient to use. The present invention provides a passenger and vehicle elevator system (10) includes a plurality of elevator cars (12, 14, 16) arrayed substantially equidistantly and equiangularly from a central shaft of the building (B). Each elevator car (12,14,16) includes a housing and at least one door (54). The housing has a floor, a ceiling, and at least one sidewall. A linearly translating platform (50) is mounted on the floor of each of the housings. The linearly translating platform (50) is adapted for automatically carrying the vehicle (V) and the at least one passenger through the at least one door (54). Further, the vehicle (V) may be rotated within the housing by driven rotation of the platform (50) or the floor, allowing for selective angular positioning of the vehicle (V) with respect to the housing. The elevator car (12) ascends and descends within a corresponding elevator shaft in a manner similar to that of a conventional elevator. In this manner, embodiments described herein seek to provide a solution to the above problems.
Patent NZ-719444-A (NZ)
Title: Novel dgat2 inhibitors
Inventor: CAMP NICHOLAS PAUL
IPC: C07D239/42
Filed: 2014-11-19
Abstract: The present invention provides compounds of the Formula below: (I) where R is H or -CH3; methods of treating patients for hypertriglyceridemia and cardiovascular diseases including dyslipidemia and atherosclerosis, and processes for preparing the compounds.
Patent NZ-719851-A (NZ)
Title: System and method for re-fracturing multizone horizontal wellbores
Inventor: BRANNON HAROLD D
IPC: E21B43/26
Filed: 2014-11-13
Abstract: A packer on a tubing string and diverting material pumped down the tubing string may be used isolate a fracture cluster in a multizone horizontal wellbore that has been previously hydraulically fractured. Once hydraulically isolated, fluid may be pumped down the tubing string to re-fracture the previously fractured fracture cluster in an effort to increase hydrocarbon production from the horizontal wellbore. The tubing string may include a testing device used to determine whether a specific fracture cluster within the horizontal wellbore should be re-fractured. Diverting material may be pumped down the tubing string and positioned adjacent a fracture cluster to hydraulically isolate the fracture cluster during the re-fracturing process. The diverting material may be cleaned out of the horizontal wellbore after all desired fracture clusters along the horizontal wellbore have been individually re-fractured.
Patent NZ-725930-A (NZ)
Title: 1h-pyrrolo[2,3-c]pyridin-7(6h)-ones and pyrazolo[3,4-c]pyridin-7(6h)-ones as inhibitors of bet proteins
Inventor: COMBS ANDREW
IPC: A61P37/00
Filed: 2015-04-22
Abstract: The present invention relates to substituted pyrrolopyridinones and substituted pyrazolopyridinones of formula I which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.
Patent NZ-740429-A (NZ)
Title: 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
Inventor: GWAK DAL-YONG
IPC: C07D413/10
Filed: 2016-08-04
Abstract: The present invention relates to novel 1,3,4-oxadiazole derivative compounds of Formula (I) having histone deacetylase 6 (HDAC6) inhibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof, the use thereof for the preparation of therapeutic medicaments, pharmaceutical compositions containing the same, a method for treating diseases using the composition, and methods for preparing the novel compounds. The novel compounds, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present invention have histone deacetylase (HDAC) inhibitory activity and are effective for the prevention or treatment of HDAC6-mediated diseases, including infectious diseases; neoplasms; endocrine, nutritional and metabolic diseases; mental and behavioral disorders; neurological diseases; diseases of the eye and adnexa; cardiovascular diseases; respiratory diseases; digestive diseases; diseases of the skin and subcutaneous tissue; diseases of the musculoskeletal system and connective tissue; or congenital malformations, deformations and chromosomal abnormalities.
Patent NZ-742219-A (NZ)
Title: Crystalline bis-ammonia transition metal molybdotungstate
Inventor: MILLER STUART
IPC: C10G49/04
Filed: 2016-12-13
Abstract: A unique crystalline bis-ammonia transition metal molybdotungstate material having the formula (NH3)2-nM(OH2)nMoxWyOz where ‘n’ varies from 0.1 to less than 2.0; ‘M’ represents a metal selected from Mg, Mn, Fe, Co, Ni, Cu, Zn and mixtures thereof; ‘x’ varies from 0.5 to 1.5; ‘y’ varies from 0.01 to 0.25; the sum of (x+y) must be ≤ 1.501; ‘z’ is a number which satisfies the sum of the valences of M, Mo and W has been developed. The material may be used as a hydroprocessing catalyst. The hydroprocessing may include hydrodenitrification, hydrodesulfurization, hydrodemetallation, hydrodearomatization, hydrodesilication, hydroisomerization, hydrotreating, hydrofining, and hydrocracking.
Patent NZ-747182-A (NZ)
Title: Ergonomic integral handle assembly
Inventor: MELLEN NICK
IPC: B65D23/10
Filed: 2017-04-04
Abstract: A method of controlling a preform for stretch blow-moulding a container with an integrally formed handle; the preform comprising a body portion and the integrally formed handle; the preform transferred from a preform supply source to a blow moulding die for blowing the container; the method including the steps of - passing the preform through a preform handle orientating apparatus, - transferring the preform to a preform transportation system, - maintaining orientation of the preform handle imposed by the preform handle orientating apparatus during transfer to the preform transportation system and transfer to the blow moulding die, - rotating the preforms during transport along the transportation system past an array of preform heating elements while shielding the integrally formed handle from excessive exposure to the heating elements, - transferring the preform from the transportation system to the blow moulding die, and wherein the handle comprises a loop of orientable material extending between an upper connection region and a lower connection region on the body portion of the preform; characterised in that the handle has a generally uniform cross section from proximate the lower connection region to a gradually widening cross section approaching the upper connection region; the cross section reaching and maintaining a maximum width proximate the upper connection region. The handle construction targets at least the problem of strain on a person’s finger when lifting such a container.
Patent NZ-756016-A (NZ)
Title: Low ph pharmaceutical composition comprising t cell engaging antibody constructs
Inventor: POMPE CORNELIUS
IPC: C07K16/28
Filed: 2018-02-02
Abstract: The present disclosure provides a low pH pharmaceutical composition comprising (a) a bi-specific antibody construct comprising a first domain binding to a target cell surface tumor antigen, a second domain binding to an extracellular epitope of the Human/Macaca CD3ε chain and a third domain that comprises 2 polypeptide monomers, which is a specific Fc modality, (b) at least one buffer agent, (c) at least one saccharide, and (d) at least one surfactant; and wherein the pH of the pharmaceutical composition is in the range of 4.0-5.0.
Patent NZ-759465-A (NZ)
Title: Electric vehicle hybrid battery system
Inventor: VANDER LIND DAMON
IPC: H01M10/46
Filed: 2017-05-30
Abstract: An electrically-powered vehicle comprising a hybrid battery system is disclosed. The vehicle comprises a motor and a hybrid battery system coupled to the motor. The hybrid battery system comprises a first battery of a first energy density and a first power density and a second battery in parallel with the first battery. The second battery has a second energy density lower than the first energy density and a second power density greater than the first power density. The vehicle is configured to draw power disproportionally from the first battery in a first mode and disproportionally from the second battery in a second mode.